coronary artery disease - concordia university...
TRANSCRIPT
CORONARY ARTERY DISEASE 1
Coronary Artery Disease
A Public Health Perspective
MPH 510: Applied Epidemiology
Concordia University, Nebraska
Andrea Eden-Shingleton
4/22/2015
CORONARY ARTERY DISEASE 2
BackgroundDisease and Setting
Coronary artery disease (CAD) is a major cause of death and disability in the developed
world. (Wilson & Douglas, 2015). In the US, about 2,150 Americans die each day from heart
disease, one every 40 seconds. (American Heart Association, 2014). Figure 1 shows the number
(in thousands) of deaths attributable to diseases of the heart in the US from 1900-2010.
(American Heart Association, 2014) In this paper, I will focus on the screening test available for
asymptomatic adult residents of the State of Ohio. The age-adjusted heart disease mortality rates
in Ohio have continued to exceed the rates for the United States from 1999–2006. (Ohio
Department of Health, 2009) The prevalence of modifiable risk factors is higher for Ohio as
compared to the United States. (Ohio Department of Health, 2009)
Introduction
50% of patients with atherosclerotic disease (CAD) are asymptomatic; they present with
either ischemic heart disease or sudden death. Yearly, for 150,000 individuals suffer a fatal heart
attack as their the first symptom of heart disease. (American Heart Association, 2004) These
individuals die suddenly without knowing they are at risk for heart disease and are unable to
receive treatment. Making a strong case for prevention, the CDC (2008) declares that sudden
death and the high cost of disability to individuals and their families are the best reasons to have
widely accessible screening programs. The CDC (2008) reported that the annual cost of CAD to
the nation in 2002 exceeded $350 billion. Including direct health care costs (for hospital and
nursing home care, physicians and other professionals, drugs and other medical durables, and
home health care) and indirect costs (due to lost productivity from disability and death), this total
CORONARY ARTERY DISEASE 3
cost substantially exceeded comparable expenditures for all cancers ($202 billion) and for human
immunodeficiency virus (HIV) infections ($28.9 billion) reported in 2002. (CDC, 2008, p. 17)
Figure 2 is a visual representation from the American Heart Association (2014) of the projected
escalating cost (total dollars in billions) of heart disease until 2030.
CORONARY ARTERY DISEASE 4
Figure 1
Figure 2
CORONARY ARTERY DISEASE 5
Epidemiology of Coronary Artery Disease
When 610,000 Americans die yearly of any disease, an epidemiologic understanding is
needed. (Center for Disease Control, 2015) Coronary artery disease is a highly preventable, but
has a high death rate due to its insidious nature. According to the National Institute of Health
(2014), taking years to slowly develop layers of fatty deposits in the circulatory system,
atherosclerosis is defined as cholesterol plaques hardening and narrowing the arteries; see figure
3. As the vessels become narrower, the potential for blood clots increase and so does the risk of
sudden death. (National Institute of Health, 2014) Another silent killer, high blood pressure
compounds the constriction of the atherosclerotic arteries; the heart is deprived of oxygen-rich
blood. (Mayo Clinic Staff, 2014) The heart muscle dies quickly without adequate blood supply;
those who survive a heart attack can be faced with the debilitating chronic ailments of congestive
heart failure and arrhythmias. (National Institute of Health, 2014)
Figure 3: Atherosclerosis in Coronary Artery and Heart Attack: (medicinenet.com, 2014)
CORONARY ARTERY DISEASE 6
Specific target population for screening for CAD
With rising cost and a high death rate, CAD risk factors need to be identified and
screened for in appropriate populations. Due to the complex nature of chronic illnesses like heart
disease, the American College of Cardiology (ACC) and the American Heart Association (AHA)
have developed clinical practice guidelines for assessment of cardiovascular risk, lifestyle
modifications to reduce cardiovascular risk, management of blood cholesterol in adults, and
management of overweight and obesity in adults in collaboration with the National Heart, Lung,
and Blood Institute (NHLBI) and other professional organizations. (Goff Jr., Lloyd-Jones,
Bennett, Coady, D’Agostino Sr., & Gibbons, 2014) Decades of research studies were
systematically reviewed to develop a pertinent strategy for reduction of deaths from heart
disease. (Goff Jr., Lloyd-Jones, Bennett, Coady, D’Agostino Sr., & Gibbons, 2014)
Researchers have found that adults, men and women, all races over the age of 40 should
be screened at their yearly physical with a primary care doctor due to behavior modifiable risk
factors. (Goff Jr., Lloyd-Jones, Bennett, Coady, D’Agostino Sr., & Gibbons, 2014) The National
Center for Biotechnology Information (NCBI, 2001) exerts that several behaviors have a strong
influence on health including diet, tobacco use, alcohol consumption, physical activity and
disease screening. Evidence has been available since the early 1980’s concerning the relationship
of certain behaviors to chronic diseases; more causal and conclusive sophisticated research like
dose-relationship studies has cemented the association. (NCBI, 2001) The slow developing
nature of heart disease in conjunction with the strong causal relationship of modifiable behaviors
demands early intervention for prevention of death due to CAD. Smoking is one of the most
preventable risk factors for stroke and heart disease and greatly elevates the risk of developing
disease. According to the Ohio Department of Health (2009) nearly one quarter (23.1 percent) of
CORONARY ARTERY DISEASE 7
Ohio adults currently smoke. In 2007, Ohio had the eighth-highest smoking prevalence in the
nation. (Ohio Department of Health, 2009) Because high blood pressure increases a person’s risk
of developing heart disease, stroke and other serious conditions, Ohio’s plan noted that in 2005,
nearly one-third of Ohio adults reported having high blood pressure. (Ohio Department of
Health, 2009) Additionally, one in ten Ohioans has been diagnosed with diabetes; another
modifiable risk factor. (Ohio Department of Health, 2009)
Common screening tests for CAD and Epidemiological data for the different tests
The common screening tests for CAD range from free to expensive, no risk to high risk
and no equipment to advanced equipment with highly trained personnel. The least expensive,
non invasive test is a cardiac risk questionnaire. Taking the questionnaire in a clinic or primary
care office, the clinician can contain basic demographic/ anthropometric information, behavioral
risk factors, genetic/ familiar links, co-morbidities and biochemical markers. This information
can be scrutinized to establish a 10 year risk assessment for future heart attack. (National Heart,
Lung and Blood Institute, 2014) Researchers have identified aging as a risk, specifically, men
over 40 years and women over 45 years. (Mayo Clinic Staff, 2014) The Mayo Clinic staff also
identify blood pressure and body mass index (BMI) are additional measurements that influence
the odds.(2014) A family history of heart disease, stroke and high blood pressure increases
possibility of CAD. (American Heart Association, 2014) Co-morbidities like diabetes and
hypercholesterolemia are also linked to heart disease. (Center for Disease Control, 2008)
Dietary habits, tobacco use and physical activity are strongly linked to CAD and are modifiable
factors. (American Heart Association, 2014) See Table below for common screening tests, their
costs and epidemiological data ( n/a- denoted that data was not available.)
CORONARY ARTERY DISEASE 8
Common Screening Test
Cost
Equipmentneeded
Sensitivity Specificity PV+ PV-
Questionnaire at home
$0 questions n/a n/a n/a n/a
Questionnaire at clinic
$0-150* Primary Care practice
n/a n/a n/a n/a
Blood test(Cholesterol, etc.)
$0-150* Access to lab n/a n/a n/a n/a
Blood pressure $0-30* Blood pressure monitor
n/a n/a n/a n/a
Electrocardiogram $500-3000*
ECG machine + cardiologist
89% 1
(with Chest Pain)
80%1
(with chest pain)
n/a n/a
Exercise Stress Test
$1000-5000*
Stress Lab + cardiologist
69%2
67%336%2
72%378%2 27%2
Myocardial Perfusion Imaging
$50-350* CT scanner +cardiologist
87%4
With chest pain
73%4
With chest pain
n/a n/a
EBCT Scanning(electron beam computerized tomography)
$50-350* CT scanner +cardiologist
62-78%5 78-100%5 83-100%5
n/a
Coronary CT angiography
$5000-10000
CT scanner+ cardiologist
98%2 74%2 90%2 94%2
*estimated cost from (Health Cost Helper, 2014)2 Information from (Ravipati, et al., 2008)
3Information from (American Heart Association, 1997)4 Information from (Fathala, 2011)5 Information from (Clouse, 2006)
Accuracy of Exercise Stress Test as a Screening Test for CAD
Chronic diseases like coronary heart disease are multi-factorial. Reducing morbidity and
mortality from CAD, two screening strategies recommended by NCBI (2001) need to be
implemented. The first involves screening for modifiable cardiac risk factors, such as
hypertension, elevated serum cholesterol, cigarette smoking, physical inactivity, and diet.
CORONARY ARTERY DISEASE 9
(National Center for Biotechnology Center, 2001, p. 1) The second strategy is early detection of
asymptomatic CAD; screening tests for this silent killer include resting electrocardiograms and
exercise stress testing. (National Center for Biotechnology Center, 2001) Myocardial Perfusion
scanning and EBCT are less commonly used for screening purposes due to cost and will not be
discussed in detail in this paper.
Resting electrocardiogram (ECG) findings include ST depression, T-wave inversion, Q
waves, and left axis deviation; all of which increase the likelihood of coronary atherosclerosis
and of future coronary events. (National Institute of Health, 2014) However, these findings are
uncommon in asymptomatic persons, occurring in only 1-4% of middle-aged men without
clinical evidence of CAD (Sox, Garber, & Littenberg, 1989) and they are not specific for
CAD. Routine ECG screening testing in asymptomatic persons with low 10 year risk of heart
attack is relatively low, is not an efficient process for detecting CAD or for predicting future
coronary events. (National Center for Biotechnology Center, 2001) In patients with active
CAD symptoms like chest pain, the sensitivity is 89% and the specificity 80%. (National
Institute for Health and Clinical Excellence, 2010)
According to research, the exercise ECG is more accurate than the resting ECG for
detecting clinically important CAD and in predicting future coronary events. (National Center
for Biotechnology Center, 2001) ECG changes often do not become apparent until an
atherosclerotic plaque has progressed to the point that it significantly impedes coronary blood
flow. (Epstein, Quyymi, & Bonow, 1989) Historically, a 1989 meta-analysis found considerable
variability in the accuracy of exercise-induced ST depression for predicting CAD (sensitivity 23-
100%, specificity 17-100%) (Gianross, Detrano, Mulvihill, & al, 1989) Currently, a literature
CORONARY ARTERY DISEASE 10
review determined the diagnostic accuracy of exercise stress testing for CAD. Banerjee,
Newman, Van den Bruel, & Heneghan (2012) examined prospective studies comparing exercise
stress testing with a reference standard of coronary angiography in patients without known CAD.
After analyzing 34 studies with 3,352 participants, the prevalence of CAD ranged from 12% to
83% and the positive and negative likelihood ratios of stress testing increased in low prevalence
settings. (Banerjee, Newman, Van den Bruel, & Heneghan, 2012) Treadmill echo testing (LR+ =
7.94) performed better than treadmill ECG testing (LR+ = 3.57) for ruling in CAD and ruling out
CAD (echo LR− = 0.19 vs. ECG LR− = 0.38). Bicycle echo testing (LR+ = 11.34) performed
better than treadmill echo testing (LR+ = 7.94), which outperformed both treadmill ECG and
bicycle ECG. This meta-analysis concluded that a positive exercise test is more helpful in
younger patients (LR+ = 4.74) than in older patients (LR+ = 2.8). (Banerjee, Newman, Van den
Bruel, & Heneghan, 2012, p. 487)
Ethical considerations in public health professional for CAD screening
There are many ethical considerations in public health. Specifically, for screening test for
CAD, the principle of justice and beneficence are paramount. Justice is equity or fairness,
especially regarding the fair distribution of benefits in the targeted population of a screening test
for CAD. (Weed & McKeown, 2001) It is evident from the higher mortality and morbidity rates
in impoverished neighborhoods that there is a lack of fair distribution of services. (Weed &
McKeown, 2001) Beneficence involves an obligation to promote benefits of things judged to be
good, weighing produced good against risks. (Weed & McKeown, 2001) In public health,
beneficence implies acting in the best interest of the population in need of prevention strategies
for the number one killer of Americans and Ohioans; heart disease. Epidemiologists must partner
CORONARY ARTERY DISEASE 11
with governmental systems to create programs that not only create awareness of heart disease
risks, but also provide affordable screening test and treatments.
Recommendations
What screening test would you recommend for adults in Ohio. Why?
When examining the various screening test available, there are a few that can be
immediately ruled out. The American College of Cardiology and the American Heart
Association do not recommended invasive testing like Coronary Artery Angiogram as first line
diagnostic test for patients presenting to emergency rooms with chest pain, due to the cost and
risk to patients; making it simple to rule this out as a screening test. Non invasive testing is safer
for patients, but some of them are expensive, making them implausible for a large scale
screening program. Tests like Myocardial Perfusion Imaging and EBCT requiring fluoroscopy,
which according to Wexler, et al (1996) is widely available, but it has several disadvantages.
The detection of calcium-depositing plaque is dependent on the skill and experience of the
operator, the number of views studied and motion of breathing artifacts. (Wexler, et al., 1996)
All factors limiting its be taken into the community.
Exercise stress testing is a well-established procedure that has been in widespread clinical
use for many decades. (Ravipati, et al., 2008) Although exercise testing is generally a safe
procedure, both myocardial infarction and death have been reported and can be expected to occur
at a rate of up to 1 per 2500 tests. (Banerjee, Newman, Van den Bruel, & Heneghan, 2012) It is
apparent that the true diagnostic value of the exercise ECG lies in its relatively high specificity,
accurately identifying patients without CAD and alerting clinicians of individuals in need of
further testing. (Ravipati, et al., 2008)
CORONARY ARTERY DISEASE 12
When examining the Likelihood Ratios (LR) for different testing modalities (see figure
4), Banerjee, Newman, Van den Bruel & Heneghan (2012) concluded that the diagnostic
accuracy of exercise testing varies, depending upon the age, gender and clinical characteristics of
the patient, the prevalence of CAD, and the modality of test used. The study found that exercise
stress testing seems most useful in low and intermediate prevalence. In high prevalence, the
change in probability will not lead to the exclusion or definite inclusion of CAD. (Banerjee,
Newman, Van den Bruel, & Heneghan, 2012) In young patients and in men, a positive exercise
test is better at discriminating CAD than in older patients and women. (Banerjee, Newman, Van
den Bruel, & Heneghan, 2012)
Figure 4 meta-analysis of included studies by patient subgroup, exercise test modality and risk of CAD
CORONARY ARTERY DISEASE 13
The accuracy of the exercise ECG for diagnosis of coronary disease in women can be
problematic. Exercise-induced ST depression is less sensitive in women than men, reflecting a
lower prevalence of severe coronary disease and the inability of many women to exercise to
maximum aerobic capacity. (Banerjee, Newman, Van den Bruel, & Heneghan, 2012) Studies
that demonstrated lower specificity in women have cited lower disease prevalence, non-Bayesian
factors, and possible hormonal differences. (Gianross, Detrano, Mulvihill, & al, 1989)
Banerjee, Newman, Van den Bruel & Heneghan (2012) report that interpretation of
exercise tests in the elderly differs somewhat from younger patients due to resting ECG
abnormalities. Nonetheless, the application of standard ST-segment response criteria to elderly
subjects is not associated with a significantly different accuracy from younger patients.
(Banerjee, Newman, Van den Bruel, & Heneghan, 2012) Due to the greater prevalence of both
CAD and severe CAD, it is not surprising that exercise testing in this group is reported to have a
slightly higher sensitivity than in younger patients. (Banerjee, Newman, Van den Bruel, &
Heneghan, 2012) A slightly lower specificity has also been reported, which may reflect the
coexistence of LVH due to valvular disease and hypertension. (American Heart Association,
1997) Regardless of the variability of the patient characteristics, the exercise stress test provides
a high accuracy for predicting future myocardial events. (Clouse, 2006)
How you would you go about increasing the participation levels in the screening?
Making exercise stress testing more readily available and lowering the cost is the way to
increase awareness and participation. Free public health screenings events are a great arena to
introduce the community to exercise stress testing. Additionally, mobile testing centers could
travel to neighborhoods where little to no primary care services currently exist. Employers can
CORONARY ARTERY DISEASE 14
increase employee awareness and promote incentive-bases healthy living programs where
occupational nurses could make referrals or invite mobile testing centers to screen employees
yearly on-site. All of these ideas will increase participation. Not only would the test be available
for little to no cost to communities, the educational awareness in the workplace would increase,
with the positive consequence of decreasing sudden cardiac death.
It is imperative for public health to play an increasing role in implementing and
sustaining evidence-based screening programs. When an epidemiologist travels to a field
assignment for an outbreak investigation, they use proven scientific methods to resolve the
deadly incident. Chronic diseases require more tenacity than outbreaks due to their multi-
factorial and insidious nature. Even if a job is difficult, the public health professional has an
ethical obligation to the public to not give up. It is our duty to influence governmental and non-
governmental agencies; shining the light on the importance of prevention of chronic disease.
Public Health organizations can provide evidence-based research to justify allocation of funds to
screening tests and policy changes.
CORONARY ARTERY DISEASE 15
References
American Heart Association. (2014, December 17). Retrieved April 22, 2015, from heart.org:
http://www.heart.org/idc/groups/ahamah-
public/@wcm/@sop/@smd/documents/downloadable/ucm_470704.pdf
American Heart Association. (1997). ACC/AHA Guidelines for Exercise Testing: Executive
Summary. Circulation , 345-354.
American Heart Association. (2013). Heart disease and stroke statistics—2014 update.
Circulation , 129, e28-e292.
American Heart Association. (2004). Heart Disease Statistical Update and Stroke Statistics.
Dallas, Texas: American Heart Association.
Banerjee, A., Newman, D., Van den Bruel, A., & Heneghan, C. (2012). Diagnostic accuracy of
exercise stress testing for coronary artery disease. International Journal of Clinical
Practice , 66 (5), 477-492.
Center for Disease Control. (2015, February 19). Retrieved April 22, 2015, from cdc.gov:
http://www.cdc.gov/heartdisease/facts.htm
Center for Disease Control. (2008). Public health action plan to prevent heart disease and
stroke: section 1. Atlanta.
Clouse, M. (2006). Controversies in cardiovascular medicine:noninvasive screening for coronary
artery disease with computed tomography is useful. Circulation , 113, 125-146.
Epstein, S., Quyymi, A., & Bonow, R. (1989). Sudden cardiac death without warning: possible
mechanisms and implications for screening asymptomatic populations. N Engl J Med ,
321, 320–323.
CORONARY ARTERY DISEASE 16
Fathala, A. (2011). Myocardial perfusion scintigraphy: techniques, interpretation,iIndications
and reporting. Ann Saudi Med , 31, 625-634.
Feigenbaum, H., Corya, B., Dillon, J., Weyman, A., Rasmussen, S., Black, M., et al. (1976).
Role of echocardiography in patients with coronary artery disease. American Journal of
Cardiology , 5, 775-786.
Gianross, i. R., Detrano, R., Mulvihill, D., & al, e. (1989). Exercise-induced ST depression in the
diagnosis of coronary artery disease: a meta-analysis. Circulation , 87-98.
Goff Jr., D., Lloyd-Jones, D., Bennett, G., Coady, S., D’Agostino Sr., R., & Gibbons, R. (2014).
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the
American College of Cardiology/American Heart Association Task Force on Practice
Guidelines. Journal of the American College of Cardiology , 63 (25), 2935-2959.
Health Cost Helper. (2014). Retrieved April 23, 2015, from http://health.costhelper.com
Mayo Clinic Staff. (2014, April 12). Retrieved April 22, 2015, from mayoclinic.org:
http://www.mayoclinic.org/diseases-conditions/coronary-artery-
disease/basics/definition/CON-20032038?p=1
National Center for Biotechnology Center. (2001). Behavioral risk factors. In Health and
behavior:the interplay of biological, behavioral and societal influences (p. 27).
Washington,DC: National Academies Press.
National Heart, Lung and Blood Institute. (2014). Retrieved April 8, 2015, from Risk
Assessment Tool for Estimating Your 10-year Risk of Having a Heart Attack:
http://cvdrisk.nhlbi.nih.gov/
CORONARY ARTERY DISEASE 17
National Institute for Health and Clinical Excellence. (2010). Chest Pain of Recent Onset:
Assessment and Diagnosis of Recent Onset Chest Pain or Discomfort of Suspected
Cardiac Origin. . Retrieved April 19, 2015, from http://www.nice.org.uk/cg95
National Institute of Health. (2014, March 17). Retrieved April 22, 2015, from nlm.nih.gov:
http://www.nlm.nih.gov/medlineplus/coronaryarterydisease.html
Ohio Department of Health. (2009). The Ohio Plan to Prevent Heart Disease and Stroke 2008–
2012 . Columbus, OH. Retrieved April 10, 2015, from
https://www.odh.ohio.gov/~/media/ODH/ASSETS/Files/hprr/cardiovascular%20health/th
eohioplantopreventheartdiseaseandstroke.ashx
Ravipati, G., Aronow, W., Lai, H., Shao, J., DeLuca, A., Weiss, M., et al. (2008). Comparison of
sensitivity, specificity, positive predictive value, and negative predictive value of stress
testing versus coronary computed tomography angiography. American Journal of
Cardiology , 101 (6), 774-775.
Sox, H., Garber, A., & Littenberg, B. (1989). The resting electrocardiogram as a screening test: a
clinical analysis. Ann Intern Med , 111, 489-502.
Weed, D., & McKeown, R. (2001). Ethics in epidemiology and public health. J Epidemiol
Community Health , 55, 855-857.
Wexler, L., Brundage, B., Crouse, J., Detrano, R., Fuster, V., Maddahi, J., et al. (1996).
Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical
implications. Circulation , 1175-1192.
Wilson, P., & Douglas, P. (2015, January 15). Retrieved April 22, 2015, from uptodate.com:
http://www.uptodate.com/contents/epidemiology-of-coronary-heart- disease?
source=search_result&search=CHD&selectedTitle=3~150
CORONARY ARTERY DISEASE 18